Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Relapsing Multiple Sclerosis”

118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 118 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Not applicableStudy completedNCT01518660
What this trial is testing

Multiple Sclerosis and Progressive Resistance Training

Who this might be right for
Multiple Sclerosis (Relapsing Remitting)
University of Aarhus 35
Not applicableUnknownNCT04993274
What this trial is testing

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Chronic Progressive
Friedemann Paul 100
Not applicableStudy completedNCT06526000
What this trial is testing

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing-remitting Multiple Sclerosis+1 more
Novartis 326
Not applicableStudy completedNCT04289909
What this trial is testing

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

Who this might be right for
Relapsing Remitting Multiple SclerosisProgressive Multiple SclerosisOptic Neuritis+4 more
Institut National de la Santé Et de la Recherche Médicale, France 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05441488
What this trial is testing

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
AB Science 800
Not applicableStudy completedNCT00888277
What this trial is testing

Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

Who this might be right for
Multiple Sclerosis, Relapsing-remittingMultiple Sclerosis, Secondary Progressive
University of Louisville 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07006805
What this trial is testing

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis (RMS)Progressive Multiple Sclerosis (PMS)Multiple Sclerosis - Relapsing Remitting+4 more
Cabaletta Bio 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,011
Large-scale testing (Phase 3)Study completedNCT00134563
What this trial is testing

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,088
Not applicableStudy completedNCT03562975
What this trial is testing

Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

Who this might be right for
Multiple SclerosisPathologic ProcessesDemyelinating Diseases+5 more
University of South Florida 18
Early research (Phase 1)Study completedNCT00559702
What this trial is testing

Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Biogen 76
Not applicableLooking for participantsNCT05964829
What this trial is testing

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Cionic, Inc. 14
Early research (Phase 1)Study completedNCT00103974
What this trial is testing

Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayhill Therapeutics 30
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT03560739
What this trial is testing

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 284
Not applicableStudy completedNCT01436838
What this trial is testing

China Betaferon Adherence, Coping and Nurse Support Study

Who this might be right for
Multiple Sclerosis, Chronic Progressive
Bayer 110
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Not applicableLooking for participantsNCT07222618
What this trial is testing

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+3 more
University of California, San Francisco 300
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Load More Results